Global Cat Vaccine Market Analysis 2026–2030 with Strategic Industry Insights

April 8, 2026April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Allogeneic T Cell Therapies Market By 2030 Starting From Its 2026 Size?

The cat vaccine market size has experienced robust growth over recent years. Forecasts show it will expand from $1.26 billion in 2025 to $1.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical growth can be linked to several factors, including the increasing incidence of feline infectious diseases, a restricted supply of advanced vaccines, an uptick in pet ownership, the expansion of veterinary clinics, and various government vaccination initiatives.

The cat vaccine market is projected to experience substantial growth in the upcoming years, with its size expected to reach $1.93 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is attributed to factors like technological advancements in vaccine development, an increasing demand for recombinant and DNA vaccines, greater awareness of preventive healthcare for pets, the expansion of online veterinary services, and the integration of AI and data analytics in disease monitoring. Major trends identified for this period include the increased adoption of core vaccination programs, the growing prominence of recombinant and DNA vaccines, the expansion of veterinary healthcare services, a rising awareness of pet health and disease prevention, and the incorporation of telemedicine and remote monitoring into veterinary care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

What Drivers Are Shaping The Future Growth Of The Allogeneic T Cell Therapies Market?

The growing incidence of zoonotic diseases is anticipated to boost the cat vaccine market moving forward. These are infections transferable from animals to humans, caused by pathogens such as bacteria, viruses, fungi, or parasites, and can spread through direct contact, vectors, or contaminated environments. Common examples include Lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis. The heightened prevalence of these diseases is attributed to factors like climate change, antimicrobial resistance, and both illicit and legitimate wildlife trade. Cat vaccines serve to control zoonotic diseases by reducing the risk of transmission from felines to humans, achieved by immunizing cats against conditions such as toxoplasmosis and cat scratch fever. This proactive strategy helps mitigate the impact of zoonotic diseases on human health, supports public health initiatives, and fosters a healthier environment for pets and their owners. For instance, a report from the Government of the United Kingdom in February 2024 revealed that England recorded 335 confirmed cases of Lyme disease in the fourth quarter of 2023, an uptick from 273 cases documented during the identical period in 2022. Thus, the escalating prevalence of zoonotic diseases is a key factor driving the cat vaccine market.

Which Segment Categories Define The Allogeneic T Cell Therapies Market?

The cat vaccine market covered in this report is segmented –

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types

2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Disease Types

3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines

4) By Route Of Administration: Injectables, Intranasal, Oral

5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:

1) By Modified Or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine

2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine

3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

What Major Market Trends Are Driving Changes In The Cat Vaccine Market?

Leading companies in the cat vaccine market are concentrating on developing innovative products such as NOBIVAC NXT vaccines, which leverage cutting-edge Ribonucleic acid (RNA)-particle technology to improve immune responses, enhance vaccine efficacy, and offer specific protection against feline diseases. This state-of-the-art Ribonucleic acid (RNA)-particle technology is an innovative methodology that uses RNA molecules enclosed within nanoparticles to deliver genetic instructions to cells, prompting them to create specific proteins that stimulate a targeted immune response. For instance, in June 2024, MSD Animal Health Inc., a US-based pharmaceutical company, introduced its NOBIVAC NXT Rabies portfolio, which includes NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies, presenting a comprehensive vaccination solution designed to provide effective defense against rabies in both cats and dogs. The NOBIVAC NXT vaccines are formulated without adjuvants and preservatives, thereby enhancing their safety profile while preserving their efficacy. These vaccines stimulate both humoral (antibody-mediated) and cell-mediated immune responses, offering extensive protection against the rabies virus.

Who Are The Top Companies Competing In The Allogeneic T Cell Therapies Market?

Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac, HIPRA Corporation, Bioveta AS, Biogénesis Bagó SA, Torigen Pharmaceuticals Inc., Vetoquinol SA, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova BV, Colorado Serum Company, Huvepharma NV, Bimeda Biologicals, CAVAC, Kyoto Biken Laboratories, Avimex Animal Health, Ringpu Biology, Wuhan Keqian Biology, Pulike Biological Engineering, Chengdu Kanghua Biological Products, Yebio, FATRO

Read the full cat vaccine market report here:

https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

Which Geographic Regions Are Influencing Demand In The Allogeneic T Cell Therapies Market?

North America was the largest region in the cat vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Allogeneic T Cell Therapies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20526&type=smp

Browse Through More Reports Similar to the Global Cat Vaccine Market 2026, By The Business Research Company

Animal Drug Compounding Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

Animal Wound Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-wound-care-global-market-report

Animal Disinfectants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-disinfectants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795